WaferGen Q1 Revenues Jump Sharply as Loss Declines | GenomeWeb

NEW YORK (GenomeWeb) – WaferGen Biosystems reported after the close of the market Thursday that its first quarter revenues jumped nearly 700 percent year over year, and the firm cut its loss sharply.

The Fremont, Calif.-based genetic analysis products firm, reported total revenues of $1.4 million for the three months ended March 31, up from $178,487 in revenues for the first quarter of 2013. Its product revenue was $1.3 million versus $95,154 year over year, while license and royalty revenue increased to $125,000 from $83,333.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.